HOUSE 19116th CongressMessage on Senate action sent to the House.
Authorizing the use of the Capitol Grounds for the Greater Washington Soap Box Derby.
- Last Action
- 4/11/2019
Actions
- 2019-12-19Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
- 2019-12-10Referred to the Subcommittee on Health.
- 2019-12-09Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-12-09Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-12-09Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-12-09Introduced in House
- 2019-12-09Introduced in House
CRS Summary
As of 2019-12-09 (00)
Lower Costs, More Cures Act of 2019
This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.
The bill generally
- limits payment amounts for drugs and biologics under Medicare medical services,
- reduces cost-sharing under the Medicare prescription drug benefit,
- modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
- revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
- establishes several reporting requirements for drug manufacturers with respect to drug prices.
Cosponsors (20)
- KEVIN BRADY (R-TX)
- Virginia Foxx (R-NC)
- Doug Collins (R-GA)
- Michael Burgess (R-TX)
- Devin Nunes (R-CA)
- Tim Walberg (R-MI)
- F. SENSENBRENNER (R-WI)
- Steve Scalise (R-LA)
- Liz Cheney (R-WY)
- FRED UPTON (R-MI)
- JOHN SHIMKUS (R-IL)
- Robert Latta (R-OH)
- Brett Guthrie (R-KY)
- Cathy Rodgers (R-WA)
- Pete Olson (R-TX)
- David McKinley (R-WV)
- Adam Kinzinger (R-IL)
- H. Griffith (R-VA)
- Gus Bilirakis (R-FL)
- Bill Johnson (R-OH)
Subjects
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Appropriations
- Biological and life sciences
- Business records
- Cancer
- Chemistry
- Child health
- Civil actions and liability
- Competition and antitrust
- Congressional oversight
- Consumer affairs
- Corporate finance and management
- Cosmetics and personal care
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug safety, medical device, and laboratory regulation
- Drug therapy
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.